Christina Dieli-conwright PhD, MPH

Christina Marie Dieli-Conwright is an Associate Professor of Medicine at Harvard Medical School and in the Division of Population Sciences of the Department of Medical Oncology at Dana-Farber Cancer Institute. She holds a secondary appointment as Associate Professor of Nutrition in the Department of Nutrition at the T.H. Chan Harvard School of Public Health and is adjunct faculty at the Joslin Diabetes Center and Boston University. Her research is focused on examining mechanisms by which post-diagnosis exercise can impact cancer prognosis, with a specific focus on biomarkers of metabolic dysregulation related to tumor growth, inflammation, gut microbiome, and body composition.

She conducts randomized controlled trials to test whether various types of prescriptive exercise improve cancer outcomes in individuals diagnosed with cancer, across the lifespan from adolescents and young adults to older adults. Additionally, Dr. Dieli-Conwright examines cardiometabolic diseases in underrepresented minority cancer survivors and utilizes lifestyle interventions to reduce the onset or exacerbation of comorbidities in said population. Dr. Dieli-Conwright has a history of funding from the National Cancer Institute, American Cancer Society, Department of Defense, Patient-Centered Outcomes Research Institute, American Institute for Cancer Research, Pfizer, and foundation grants.

Before joining DFCI in 2020, she was the Director of the Integrative Center for Oncology Research in Exercise and an Assistant Professor of Biokinesiology and Medicine at the University of Southern California (USC). She completed a postdoctoral fellowship at the City of Hope National Medical Center after earning her PhD in Biokinesiology from USC.